Article
Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine.
The American journal of gastroenterology - 1 Jan 1999
Yoshioka K, Yano M, Kusakabe A, Hirofuji H, Fuji A, Kuriki J, Arao M, Murase K, Kidokoro R, Kakumu S
Abstract excerpt
OBJECTIVE: We conducted a randomized controlled trial to compare the efficacy of two different dosages of lymphoblastoid interferon alpha (IFN) for the treatment of chronic hepatitis C. METHODS: Eighty-four patients with chronic hepatitis C were enrolled and randomly assigned into the two groups;...
Topics
- Antiviral Agents
- Female
- Genotype
- Hepacivirus
- Hepatitis C, Chronic
- Humans
- Interferon-alpha
- Male
- Middle Aged
- Multivariate Analysis
- RNA, Viral
- Viral Load